Madlen Jentzsch Selected Research

Madlen Jentzsch Research Topics

18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 01/2016
4	Multiple Myeloma 08/2021 - 11/2015
4	Neoplasms (Cancer) 03/2021 - 12/2019
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 01/2019
3	Leukemia 10/2020 - 04/2017
3	Pathologic Complete Response 01/2020 - 04/2017
2	Lymphoma (Lymphomas) 01/2021 - 01/2021
2	Residual Neoplasm 01/2020 - 04/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Weight Loss (Weight Reduction) 03/2021
1	Large Granular Lymphocytic Leukemia 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Sezary Syndrome (Sezary Erythroderma) 01/2021
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 05/2020
1	Septic Shock (Toxic Shock Syndrome) 05/2020
1	Bacterial Meningitis 05/2020
1	Sepsis (Septicemia) 05/2020
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 01/2020
1	Mast-Cell Sarcoma 01/2020
1	Wilms Tumor (Wilm's Tumor) 02/2019
1	Thrombotic Thrombocytopenic Purpura 05/2015
1	acquired Thrombotic thrombocytopenic purpura 05/2015
1	Pancreatitis 05/2015

5	Bendamustine Hydrochloride FDA Link 08/2021 - 11/2015
3	Bortezomib (Velcade)FDA Link 08/2021 - 11/2015
3	Prednisone (Sone)FDA LinkGeneric 08/2021 - 11/2015
2	Biological ProductsIBA 11/2021 - 04/2017
2	Rituximab (Mabthera)FDA Link 01/2021 - 05/2015
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2022
1	Chimeric Antigen ReceptorsIBA 01/2021
1	polatuzumab vedotinIBA 01/2021
1	Brentuximab VedotinIBA 01/2021
1	eculizumab FDA Link 05/2020
1	Complement Inactivating AgentsIBA 05/2020
1	CPX-351IBA 01/2020
1	NucleophosminIBA 02/2019
1	Lenalidomide (CC 5013)FDA Link 12/2017
1	Prednisolone (Predate)FDA LinkGeneric 12/2017
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	fludarabineIBA 01/2016
1	Amsacrine (AMSA)IBA 01/2016
1	AutoantibodiesIBA 05/2015
1	thiamine triphosphorate (TTP)IBA 05/2015
1	Metalloproteases (Metalloproteinases)IBA 05/2015

11	Stem Cell Transplantation 10/2022 - 11/2015
11	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2016
10	Therapeutics 11/2021 - 04/2017
5	Drug Therapy (Chemotherapy) 03/2021 - 04/2017
4	Homologous Transplantation 01/2020 - 04/2017
2	Hematopoietic Stem Cell Mobilization 01/2022 - 11/2015
1	Salvage Therapy 01/2021
1	Transplantation 01/2021
1	Radiotherapy 01/2020